{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:44:34Z","timestamp":1794357874470,"version":"4.9.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,2]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>RAPA-resistant mTOR negatively regulates DC B7-H1 expression through signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3. Adenosine triphosphate\u2013competitive mTOR inhibition promotes B7-H1\u2013dependent DC induction of Tregs.<\/jats:p>","DOI":"10.1182\/blood-2012-08-448290","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T11:10:07Z","timestamp":1361963407000},"page":"3619-3630","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction"],"prefix":"10.1182","volume":"121","author":[{"given":"Brian R.","family":"Rosborough","sequence":"first","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e0lia","family":"Ra\u00efch-Regu\u00e9","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Matta","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunwook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Experimental Radiation Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"DePinho","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Hackstein","sequence":"additional","affiliation":[{"name":"Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen and German Center for Lung Research, Giessen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boothby","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine, Nashville, TN;"},{"name":"Department of Medicine (Rheumatology), Vanderbilt University School of Medicine, Nashville, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u0113th R.","family":"Turnquist","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;"},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;"},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111816451538100_B1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells.","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2019111816451538100_B2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance.","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2019111816451538100_B3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"issue":"29","key":"2019111816451538100_B4","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111816451538100_B5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol"},{"issue":"12","key":"2019111816451538100_B6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"issue":"13","key":"2019111816451538100_B7","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"issue":"5","key":"2019111816451538100_B8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition.","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2019111816451538100_B9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"issue":"11","key":"2019111816451538100_B10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"issue":"14","key":"2019111816451538100_B11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"issue":"67","key":"2019111816451538100_B12","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition.","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci Signal"},{"issue":"12","key":"2019111816451538100_B13","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.","volume":"284","author":"Thoreen","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111816451538100_B14","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol"},{"issue":"2","key":"2019111816451538100_B15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1600-6143.2004.00673.x","article-title":"Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival.","volume":"5","author":"Taner","year":"2005","journal-title":"Am J Transplant"},{"issue":"1","key":"2019111816451538100_B16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4049\/jimmunol.181.1.62","article-title":"IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.","volume":"181","author":"Turnquist","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"2019111816451538100_B17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response.","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"issue":"11","key":"2019111816451538100_B18","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/eji.200838761","article-title":"Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.","volume":"38","author":"Schmitz","year":"2008","journal-title":"Eur J Immunol"},{"issue":"23","key":"2019111816451538100_B19","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1182\/blood-2009-10-251488","article-title":"mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.","volume":"115","author":"Turnquist","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111816451538100_B20","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.","volume":"185","author":"Haidinger","year":"2010","journal-title":"J Immunol"},{"issue":"9","key":"2019111816451538100_B21","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.1002513","article-title":"Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-\u03b2-signaling pathways regulates the innate inflammatory response.","volume":"186","author":"Wang","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"2019111816451538100_B22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.immuni.2010.06.002","article-title":"Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.","volume":"32","author":"Lee","year":"2010","journal-title":"Immunity"},{"issue":"4","key":"2019111816451538100_B23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"2019111816451538100_B24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-09-2340","article-title":"Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.","volume":"70","author":"Yu","year":"2010","journal-title":"Cancer Res"},{"issue":"5","key":"2019111816451538100_B25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1189\/jlb.0311119","article-title":"Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.","volume":"91","author":"Rosborough","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2019111816451538100_B26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res"},{"issue":"11","key":"2019111816451538100_B27","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.","volume":"178","author":"Turnquist","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"2019111816451538100_B28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.febslet.2005.12.093","article-title":"Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).","volume":"580","author":"Lee","year":"2006","journal-title":"FEBS Lett"},{"issue":"52","key":"2019111816451538100_B29","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111816451538100_B30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/eji.201040979","article-title":"PD-L1 expression on tolerogenic APCs is controlled by STAT-3.","volume":"41","author":"W\u00f6lfle","year":"2011","journal-title":"Eur J Immunol"},{"issue":"11","key":"2019111816451538100_B31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system.","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111816451538100_B32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ni.1729","article-title":"Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.","volume":"10","author":"Dejean","year":"2009","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111816451538100_B33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI44325","article-title":"FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.","volume":"121","author":"Watkins","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111816451538100_B34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2010.10.019","article-title":"FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.","volume":"18","author":"Gan","year":"2010","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111816451538100_B35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation.","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111816451538100_B36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(02)00449-1","article-title":"SOCS-1 participates in negative regulation of LPS responses.","volume":"17","author":"Nakagawa","year":"2002","journal-title":"Immunity"},{"issue":"20","key":"2019111816451538100_B37","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.202477099","article-title":"Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.","volume":"99","author":"Seki","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111816451538100_B38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ni932","article-title":"SOCS3 regulates the plasticity of gp130 signaling.","volume":"4","author":"Lang","year":"2003","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111816451538100_B39","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"2019111816451538100_B40","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood-2006-08-041541","article-title":"Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.","volume":"110","author":"Brender","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2019111816451538100_B41","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","article-title":"Rapamycin inhibits IL-4\u2013induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo.","volume":"101","author":"Hackstein","year":"2003","journal-title":"Blood"},{"issue":"7","key":"2019111816451538100_B42","doi-asserted-by":"crossref","first-page":"e21949","DOI":"10.1371\/journal.pone.0021949","article-title":"IL-1\u03b2 promotes TGF-\u03b21 and IL-2 dependent Foxp3 expression in regulatory T cells.","volume":"6","author":"Ganesh","year":"2011","journal-title":"PLoS ONE"},{"issue":"8","key":"2019111816451538100_B43","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/eji.201141523","article-title":"The influence of mTOR on T helper cell differentiation and dendritic cell function.","volume":"41","author":"Salmond","year":"2011","journal-title":"Eur J Immunol"},{"issue":"2","key":"2019111816451538100_B44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB.","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"issue":"3","key":"2019111816451538100_B45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood-2008-02-137430","article-title":"Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.","volume":"112","author":"Ohtani","year":"2008","journal-title":"Blood"},{"issue":"52","key":"2019111816451538100_B46","doi-asserted-by":"crossref","first-page":"44295","DOI":"10.1074\/jbc.M111.258053","article-title":"Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.","volume":"286","author":"Brown","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111816451538100_B47","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.4049\/jimmunol.1200069","article-title":"Cutting edge: mTORC1 in intestinal CD11c+ CD11b+ dendritic cells regulates intestinal homeostasis by promoting IL-10 production.","volume":"188","author":"Ohtani","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"2019111816451538100_B48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"2019111816451538100_B49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"2019111816451538100_B50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000087945","article-title":"Patterns of pulmonary complications associated with sirolimus.","volume":"73","author":"Chhajed","year":"2006","journal-title":"Respiration"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/18\/3619\/1363512\/3619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/18\/3619\/1363512\/3619.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T21:45:32Z","timestamp":1574113532000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/18\/3619\/31300\/Murine-dendritic-cell-rapamycinresistant-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,2]]},"references-count":50,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013,5,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-08-448290","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,2]]}}}